» Articles » PMID: 34013402

Heterogeneity of SARS-CoV-2 Virus Produced in Cell Culture Revealed by Shotgun Proteomics and Supported by Genome Sequencing

Abstract

COVID-19 is the most disturbing pandemic of the past hundred years. Its causative agent, the SARS-CoV-2 virus, has been the subject of an unprecedented investigation to characterize its molecular structure and intimate functioning. While markers for its detection have been proposed and several diagnostic methodologies developed, its propensity to evolve and evade diagnostic tools and the immune response is of great concern. The recent spread of new variants with increased infectivity requires even more attention. Here, we document how shotgun proteomics can be useful for rapidly monitoring the evolution of the SARS-CoV-2 virus. We evaluated the heterogeneity of purified SARS-CoV-2 virus obtained after culturing in the Vero E6 cell line. We found that cell culture induces significant changes that are translated at the protein level, such changes being detectable by tandem mass spectrometry. Production of viral particles requires careful quality control which can be easily performed by shotgun proteomics. Although considered relatively stable so far, the SARS-CoV-2 genome turns out to be prone to frequent variations. Therefore, the sequencing of SARS-CoV-2 variants from patients reporting only the consensus genome after its amplification would deserve more attention and could benefit from more in-depth analysis of low level but crystal-clear signals, as well as complementary and rapid analysis by shotgun proteomics.

Citing Articles

Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages.

Prince T, Dong X, Penrice-Randal R, Randle N, Hartley C, Goldswain H mSphere. 2022; 7(3):e0091321.

PMID: 35491827 PMC: 9241508. DOI: 10.1128/msphere.00913-21.


Matrix-Assisted Laser Desorption and Ionization Time-of-Flight Mass Spectrometry Analysis for the Direct Detection of SARS-CoV-2 in Nasopharyngeal Swabs.

Yoshinari T, Hayashi K, Hirose S, Ohya K, Ohnishi T, Watanabe M Anal Chem. 2022; 94(10):4218-4226.

PMID: 35238540 PMC: 8903212. DOI: 10.1021/acs.analchem.1c04328.


Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2.

Armengaud J EBioMedicine. 2021; 69:103480.

PMID: 34252697 PMC: 8270654. DOI: 10.1016/j.ebiom.2021.103480.

References
1.
Dutta N, Mazumdar K, Gordy J . The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development. J Virol. 2020; 94(13). PMC: 7307180. DOI: 10.1128/JVI.00647-20. View

2.
Armero A, Berthet N, Avarre J . Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia. Viruses. 2021; 13(1). PMC: 7833370. DOI: 10.3390/v13010133. View

3.
Davidson A, Kavanagh Williamson M, Lewis S, Shoemark D, Carroll M, Heesom K . Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein. Genome Med. 2020; 12(1):68. PMC: 7386171. DOI: 10.1186/s13073-020-00763-0. View

4.
Hoffmann M, Arora P, Gross R, Seidel A, Hornich B, Hahn A . SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021; 184(9):2384-2393.e12. PMC: 7980144. DOI: 10.1016/j.cell.2021.03.036. View

5.
Luo R, Delaunay-Moisan A, Timmis K, Danchin A . SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done. Environ Microbiol. 2021; 23(5):2339-2363. PMC: 8251359. DOI: 10.1111/1462-2920.15487. View